Find clinical trials for Non-Small-Cell Lung Cancer in New Haven, CT
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Small-Cell Lung Cancer trials near New Haven, CT, USA:
body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) t...
Phase 2
Hartford, Connecticut, United States of America and 8 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Port Jefferson, New York, United States and 83 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
New Haven, Connecticut, United States and 126 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
New Haven, Connecticut, United States and 137 other locations
in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...
Phase 3
Port Jefferson Station, New York, United States and 210 other locations
and radiation therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal ant ...
Phase 1
New Haven, Connecticut, United States and 2 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Shirley, New York, United States and 230 other locations
and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...
Phase 1
New Haven, Connecticut, United States and 30 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...
Phase 3
West Haven, Connecticut, United States and 219 other locations
checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC tumors at multiple study sites. The main objectives of the study are to ...
Phase 2
Stony Brook, New York, United States and 2 other locations
Clinical trials
Research sites
Resources
Legal